AndrewHSmithMD

PubMed

• 5 citations
  Tissue plasminogen activator treatment of bilateral pulmonary emboli in a pediatric patient supported with a ventricular assist device.
  Justin Godown, Debra A. Dodd, Thomas P. Doyle, Andrew H. Smith, Dana Janssen, Bret A. Mettler> ;Pediatric Transplantation. 2015 Nov 1
• Cardiac critical care: what really makes a difference.
  Smith, A. H.,Laussen, P. C.> ;Curr. Opin. Pediatr.. 2013 Aug 29
• Relation of Milrinone After Surgery for Congenital Heart Disease to Significant Postoperative Tachyarrhythmias.
  Smith, A.H., Owen, J., Borgman, K.Y., Fish, F.A., Kannankeril, P.J.> ;Am J Cardiol. 2011 Dec 1
• A Genetic Contribution to Risk for Postoperative Junctional Ectopic Tachycardia in Children Undergoing Surgery for Congenital Heart Disease.
  Borgman, K.Y., Smith, A.H., Owen, J.P., Fish, F.A., Kannankeri, P.J.> ;Heart Rhythm. 2011 Dec
• Acute renal failure during extracorporeal support in the pediatric cardiac patient.
  Smith, A.H., Hardison, D.C., Worden, C.R., Fleming, G.M., Taylor, M.B.> ;ASAIO J. 2009-07-01
• Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition.
  Hu, X., Dietz, J.D., Xia, C., Knight, D.R., Loging, W.T., Smith, A.H., Yuan, H., Perry, D.A., Keiser, J.> ;Endocrinology. 2009-05-01
• Autonomic tone attenuates drug-induced QT prolongation.
  Smith, A.H., Norris, K.J., Roden, D.M., Kannankeril, P.J.> ;J Cardiovasc Electrophysiol. 2007 Sep
• The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbits.
  Flynn, D.M., Smith, A.H., Treadway, J.L., Levy, C.B., Soeller, W.C., Boettner, W.A., Wisniecki, P., Plowchalk, D.R., Gernhardt, S.S., Tracey, W.R., Knight, D.R.> ;Cardiovasc Drugs Ther. 2005 Oct
• 6 citations
  High ankle sprains: minimizing the frustration of a prolonged recovery.
  Andrew H. Smith, Bernard R. Bach> ;The Physician and Sportsmedicine. 2004 Dec 1
• Rash After ACL Reconstruction: Asking the Right Questions.
  Andrew H. Smith, Bernard R. Bach> ;The Physician and Sportsmedicine. 2004 Oct 1
• Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.
  Tracey, W.R., Treadway, J.L., Magee, W.P., Sutt, J.C., McPherson, R.K., Levy, C.B., Wilder, D.E., Yu, L.J., Chen, Y., Shanker, R.M., Mutchler, A.K., Smith, A.H., Flynn...> ;Am J Physiol Heart Circ Physiol. 2004 Mar
• Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury.
  Tracey, W.R., Magee, W.P., Oleynek, J.J., Hill, R.J., Smith, A.H., Flynn, D.M., Knight, D.R.> ;Am J Physiol Heart Circ Physiol. 2003 Dec
• CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(-/-) mice.
  Aiello, R. J., Perry, B. D., Bourassa, P. A., Robertson, A., Weng, W., Knight, D. R., Smith, A. H., Frederick, K. S., Kalgutkar, A., Gladue, R. P.> ;Atherosclerosis. 2010 Feb 01
• NO modulates myocardial O2 consumption in the nonhuman primate: an additional mechanism of action of amlodipine.
  Forfia, P. R., Zhang, X., Knight, D. R., Smith, A. H., Doe, C. P., Wolfgang, E. A., Flynn, D. M., Wolin, M. S., Hintze, T. H.> ;Am J Physiol. 1999 Jun
• CP-71,362: a pentapeptide renin inhibitor selective for the canine enzyme.
  Mangiapane, M. L., MacAndrew, J. T., Ellery, S. S., Smith, A. H., Purcell, I. M., Kleinman, E. F., Holt, W. F., Murphy, W. R.> ;Clin Exp Hypertens. 1994 Jul
• Measurement of organ blood flow with coloured microspheres in the rat.
  Hakkinen, J. P., Miller, M. W., Smith, A. H., Knight, D. R.> ;Cardiovasc Res. 1995 Jan
• A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo.
  Knight, D. R., Smith, A. H., Flynn, D. M., MacAndrew, J. T., Ellery, S. S., Kong, J. X., Marala, R. B., Wester, R. T., Guzman-Perez, A., Hill, R. J., Magee, W. P., Tra...> ;J Pharmacol Exp Ther. 2001 Apr
• Andersen-Tawil syndrome.
  Smith, A. H., Fish, F. A., Kannankeril, P. J.> ;Indian Pacing Electrophysiol J. 2006
• Tachycardia-induced primate model of heart failure in cardiovascular drug discovery.
  Smith, A. H., Wolfgang, E. A., Flynn, D. M., Doe, C. P., Knight, D. R.> ;J Pharmacol Toxicol Methods. 2000 Mar 01
• Sas-4 provides a scaffold for cytoplasmic complexes and tethers them in a centrosome.
  Gopalakrishnan, J., Mennella, V., Blachon, S., Zhai, B., Smith, A. H., Megraw, T. L., Nicastro, D., Gygi, S. P., Agard, D. A., Avidor-Reiss, T.> ;Nat Commun. 2011
• Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury.
  Tracey, W. R., Magee, W. P., Ellery, C. A., MacAndrew, J. T., Smith, A. H., Knight, D. R., Oates, P. J.> ;Am J Physiol Heart Circ Physiol. 2000 Oct
• Join now to see all